---
title: "AI in Validated Environments: LLMs Inside the GxP Boundary"
date: 2026-08-30
description: "The governance question sponsors actually ask about LLMs, how GAMP 5 and CSA risk-based assurance frame AI-assisted programming, and where human accountability sits."
tags: ["clinical-sas", "sce", "ai", "gxp", "validation"]
kind: tutorial
series: clinical-sp-bootcamp
seriesOrder: 14
canonicalPath: /blog/ai-in-validated-environments.html
draft: true
---

The question arrives in the kickoff meeting, from the sponsor's QA lead, and it is never "can the model write SAS." It is: "If a reviewer asks how this table was produced, what exactly do we show them?" The room goes quiet, because the honest draft answer ("an assistant drafted the program, a programmer touched it up, the QC passed") is not yet shaped like an answer an auditor accepts. Closing that gap is the actual work of bringing LLMs into validated environments; the capability question is mostly settled, and this part is about the governance one.

> **TL;DR** — Regulated AI adoption is an assurance problem, not a capability problem. GAMP 5 2nd edition and CSA give you the risk-based frame: assure in proportion to risk, and validate artifacts, not every tool that touched them. Inside Domino-class SCEs, AI arrives as governed assistants with traceable diffs; the human who signs the validation record keeps the accountability. The post closes with the three-line policy a team can adopt on Monday.

## The fundamentals

### What validated means, in practice

Computer system validation is documented evidence that a system does what it is supposed to do, reliably, under control. For pharma software, the practical duties are stable across decades: requirements written down, testing against those requirements, defects handled, change controlled, and a state you can reconstruct later: version, configuration, data, and the people who touched each. "Validated environment" names the place where those duties are met for the systems that produce regulated content.

The industry's GAMP framework added a vocabulary for grading systems by risk and by how configurable or bespoke they are. The point of the grading was always proportionality: a spreadsheet template and a custom clinical database do not warrant the same assurance dossier, and pretending otherwise burns quality resources on the wrong targets.

### The risk-based turn: GAMP 5 Second Edition and CSA

The second edition of GAMP 5, together with FDA's computer software assurance (CSA) direction, made proportionality explicit: assurance effort should scale with risk to patient safety and product quality, and critical thinking should replace rote scripted testing where the risk does not demand scripts. CSA in particular pushes unscripted and exploratory testing for lower-risk features, with the rationale documented: test less formulaically, but record and justify what you did.

For AI-assisted programming, this frame lands somewhere useful. Asking "is the LLM validated?" is a category error, as the next section shows. The question that works is "what can go wrong if this component misbehaves, and what evidence do we need that it did not?" That is a question a statistical programming team can actually answer, criterion by criterion, output by output.

### The assistant is tooling; the artifact is the deliverable

Here is the distinction that resolves most of the panic. When a programmer uses an LLM to draft a SAS program, two different things exist afterward:

- **The assistant**: a nondeterministic tool that suggested text. Like a compiler, a text editor, or a macro library inherited from a colleague, it is part of the means of production.
- **The artifact**: the program, the dataset, the TLF. This is what enters the regulated record, and it carries the same obligations it always did: specification, execution, independent QC, review, approval.

You validate the artifact and the process that produces it. Nobody validates their text editor, and nobody ships its undo history either.

One property separates an LLM from a compiler, and it matters: a compiler fails loudly and deterministically; an LLM fails quietly and plausibly. A hallucinated PROC option looks exactly like a real one, and a fluently wrong derivation reads like a correct one. That does not change where validation lands. It shifts the weight onto the gate: the deterministic checks and the independent human review that every artifact passes through regardless of who or what typed the first draft.

| Component | Role | Deterministic? | How it is assured |
|---|---|---|---|
| LLM assistant | Drafting tool | No | Usage policy; traceable sessions; human review of diffs |
| Generated program | Artifact | Yes, once written | Standard validation: compile, QC compare, review |
| Pipeline and gates | Process | Yes | Versioned, tested, rerun evidence per run |
| Run record | Evidence | Yes | Platform audit trail; input and output hashes |
| Human sign-off | Accountability | — | A named owner signs the validation record |

*Table 1: The assistant-versus-artifact split, component by component. The assurance column never says "validate the model."*

### The boundary that does not move

Every artifact that enters a submission has a person behind it: the one who signed. Tools change; the signature does not delegate. Whatever drafted the code, the validation record names a human who reviewed the evidence and took responsibility for the output. That is the accountability boundary, and no capability advance moves it; an organization that cannot name who owns an output has a governance problem with or without AI in the room.

## The modern workflow

### Where AI sits in SCE platforms today

In Domino-class SCEs (the governed cloud platforms Part 1 described), AI arrives as a platform feature rather than a side channel. Three capabilities define the current category, and you should verify each against your actual platform, because offerings differ and change quickly:

- **Governed assistant access.** Coding assistants are reached through the platform itself, so study data stays inside the boundary instead of traveling to an external consumer endpoint by default.
- **Traceable AI contributions.** Assistant sessions are tied to the project and the user, so a suggested diff is attributable (who prompted, what was suggested, what was accepted) and is reviewed like any other change.
- **Auditable sessions.** Where the platform provides assistants, prompts and outputs can be captured by the same audit trail that captures runs, giving QA something to inspect after the fact.

I am describing the category as vendors present it, not certifying any product. The verification step before adoption (what is actually enforced, what is logged, what the configuration options are) is exactly the diligence a CSA-minded team should run anyway.

### The pattern end to end

The working pattern has not changed since the drafting tools did; it is draft, gate, sign, and the clinical version is laid out in [AI coding assistants for clinical programmers](/blog/ai-coding-assistants-sas-gxp.html). An SCE makes each step enforceable:

1. **Draft.** The assistant, inside the platform, proposes code or a fix. The prompt and the proposal are recorded with the session.
2. **Gate.** Deterministic checks run: compilation, assertions, the independent QC comparison. No model sits inside the gate. A minimal Study XYZ version:

```python
import pandas as pd
primary = pd.read_sas("output/adam/adsl.xpt", format="xport")
qc      = pd.read_sas("output/qc/qc_adsl.xpt", format="xport")
assert primary.shape == qc.shape, "structure mismatch"
assert (primary.USUBJID.sort_values().values ==
        qc.USUBJID.sort_values().values).all(), "subject mismatch"
print("gate PASS - independent QC agrees")
```

3. **Review.** A human reads the diff with the gate evidence attached, not the assistant's prose, and approves or rejects in a pull request, the flow Part 12 built.
4. **Sign.** The validation record names the owner. The archived prompt, the raw output, the model version, and the gate log attach to that record.

Note what the SCE adds: the gate is not a personal habit, it is a pipeline stage (Part 13); the archive is not a folder someone maintains, it is the run history; the access rule is not a slide, it is the platform boundary.

### Reproducibility lives outside the model

Sponsors ask one more question: "will it produce the same thing next time?" The honest answer about any hosted LLM is no: not across model versions, sometimes not across identical calls. Setting temperature to zero buys greedy sampling, not stability; my note on [temperature 0 and reproducibility](/blog/note-temperature-zero.html) covers why in five minutes. The consequence is architectural: hash and version everything the model touched, so drift is detected rather than silently absorbed, and treat replayability as a property of the pipeline, never of the sampler.

This is also where free-form agent use breaks. An agent improvising its own path through a study cannot replay its run and effectively grades its own homework; the structural failure modes are laid out in [why LLM agents fail at regulated programming](/blog/why-llm-agents-fail-regulated-programming.html). The fix there was a fixed process DAG with typed, gated steps; at study scale, that DAG is exactly the pipeline from Part 13.

### A three-line policy

Strip everything above to what a team can adopt on Monday:

1. **Explore freely — on synthetic and public data.** Any capable tool, any prompt; learn what it can and cannot do. The boundary is the data, not the curiosity.
2. **On study data — approved assistants only, inside the platform, logged.** No consumer chatbots, no pasting patient-level data or confidential protocol text outside approved channels. The SCE's governed access makes this enforceable rather than aspirational.
3. **Humans own the artifacts.** Every AI-touched diff is reviewed like a first draft, the gates stay deterministic, and a named person signs the record.

Three lines fit on a slide, survive a reorganization, and map onto the assurance logic above: line 1 drives sandbox risk toward zero, line 2 contains data risk, line 3 fixes accountability. Every elaborate AI policy I have seen eventually reduces to these three lines plus definitions.

### What sponsors actually accept

Acceptance has moved from "whether" to "under what controls" for drafting use cases: programs drafted with assistant help, QC'd independently, reviewed by a human, with the trail preserved. What decides the conversation is the verification story: whether you can show the gate evidence on demand. I have seen no rigorous public survey of inspector attitudes toward AI-assisted programming, and I would not quote an invented one to a QA group; what travels well is the process record. Pilot one workflow, keep the record, review it with QA in the room, then expand; the sequence is CSA-shaped (proportionate, documented, reversible).

## The agentic way

The next shift is already visible: agents that execute the whole draft-gate-sign loop, rerunning pipelines, triaging failed runs, proposing fixes, opening pull requests. Inside a fixed DAG with deterministic gates, this is tractable: each agent action lands on a reviewable artifact, and the gates do not care who or what produced the diff.

The new failure mode is unreviewed momentum. A chain of agent actions, each individually plausible, can move faster than the review cadence, and the record starts to look like an audit trail of decisions nobody made consciously. The countermeasures are the ones this part built: a fixed workflow, deterministic gates, agent actions logged as first-class audit events with attribution, and a human named on the record. The SCE is where those controls are enforceable at platform level. That is why the agentic era makes the environment, not the model, the decisive choice.

<div class="era-callout">
  <p><strong>The agentic way</strong> — Agents move from drafting single programs to executing whole gated workflows: rerun the pipeline, triage the log, propose the fix, open the PR. The failure mode is unreviewed momentum — a chain of agent actions, each plausible, none individually owned. The controls are the ones this part built: fixed workflow, deterministic gates, agent actions logged as audit events, a human named on the record.</p>
  <p class="era-callout-asof">Volatile layer — last verified 2026-08-30. Re-verify before relying on tool specifics.</p>
</div>

## Key takeaways

- The sponsor's question is evidentiary ("what do we show the reviewer"), not a capability question; answer it with process, not demos.
- GAMP 5 2nd edition and CSA support a risk-based approach: validate artifacts and processes in proportion to risk; "validate the LLM" assigns the obligation to the wrong object.
- The assistant/artifact split does the heavy lifting: nondeterministic tooling outside the record, deterministic gates and human review on everything inside it.
- Domino-class SCEs make AI governable in practice: assistant access inside the boundary, attributable diffs, prompts and outputs captured in the audit trail.
- The three-line policy (explore on synthetic data, approved assistants on study data, humans own the artifacts) is the minimum viable governance.

## FAQ

### Does GAMP 5 cover AI and machine learning tools?

The second edition emphasizes critical thinking and modern approaches rather than enumerating technologies, so AI tooling fits its categories when you classify by role and risk. An assistant that drafts code is tooling; a model whose output enters the record directly is a different and heavier conversation. The frame to bring to QA is the manual's own: assurance proportional to risk, with the rationale documented.

### Do we need to validate the LLM itself?

No, and you mostly cannot: it is a changing, externally served system you do not control. What you validate is the process around it: the deterministic gates, the independent QC, the review, the records. Your obligation is that artifacts are trustworthy and traceable, not that a vendor's weights are.

### Can programmers use consumer chatbots on study data?

No, and this is the least negotiable of the three lines. Study data goes only to tools inside the approved boundary, with logging and access control. Consumer tools offer no data protection commitment you can point to, no audit trail, and no accountability chain. Synthetic and public data is where consumer tools belong.

### What will an inspector ask about AI-assisted code?

Expect process questions: how was this program produced and checked, what controls govern assistant use, who reviewed it, and who signed. A run record with the diff, the gate log, the archived prompt and model version, and a named reviewer answers all four. The uncomfortable position is having no record of assistant involvement at all.

### How should a team start?

One workflow, one study, the three-line policy, and a short written procedure: which assistants are approved, for which data, and what evidence each AI-touched artifact must carry. Review after a month with QA in the room, then expand. Bottom-up adoption with a record beats a corporate policy written before anyone ran a pilot.

---

**Series navigation** — Previous: [Part 13: Pipeline as Code](/blog/pipeline-as-code-sdtm-adam.html) · Series home: [Part 0: The Clinical SP Bootcamp roadmap](/blog/clinical-sp-bootcamp-roadmap.html)

This part is the bridge between the bootcamp and the AI line: [AI coding assistants for clinical programmers](/blog/ai-coding-assistants-sas-gxp.html) covers the drafting use cases in depth, and [why LLM agents fail at regulated programming](/blog/why-llm-agents-fail-regulated-programming.html) makes the structural argument for fixed workflows. [Temperature 0 doesn't buy you reproducibility](/blog/note-temperature-zero.html) is the five-minute version of the reproducibility section.
